Department of Community Health and Social Sciences, City University of New York's Graduate School of Public Health and Health Policy, 55 West 125th Street, New York, NY, 10027, United States of America.
Department of Health Policy and Management, City University of New York's Graduate School of Public Health and Health Policy, 55 West 125th Street, New York, NY, 10027, United States of America.
Health Res Policy Syst. 2022 Oct 8;20(1):106. doi: 10.1186/s12961-022-00921-3.
The economic downfall in Lebanon and the destruction of the Beirut Port have had a crippling effect on all players in the health sector, including hospitals, healthcare providers, and the pharmaceutical and medical supply industry. The outbreak of COVID-19 has further aggravated the crisis. To address the challenges facing the pharmaceutical industry, Lebanon must create a stable and secure source of prescription drug production. Two alternative approaches are presented to address the crisis: (1) amending the subsidy system and supporting local pharmaceutical production, and (2) promoting the prescription and use of generic drugs. Investing in local production is promising and can lead to establishing trust in the quality of drugs produced locally. These efforts can be complemented by promoting the prescription and use of generic drugs at a later stage, after having had established a well-operating system for local drug production.
黎巴嫩的经济崩溃和贝鲁特港的破坏对卫生部门的所有参与者都产生了严重影响，包括医院、医疗服务提供者以及制药和医疗供应行业。COVID-19 的爆发进一步加剧了危机。为了解决制药行业面临的挑战，黎巴嫩必须为处方药生产创造一个稳定和安全的来源。有两种方法可以用来解决这个问题：（1）修改补贴制度，支持当地制药生产；（2）促进使用通用名药物。投资于当地生产是有希望的，可以建立对当地生产药品质量的信任。在建立了一个运作良好的当地药品生产系统之后，可以通过推广使用通用名药物来补充这些努力。
